More meds available through province's drug program
The Telegram
The province is adding seven new prescription drugs to its list of medications available under the Prescription Drug Program.
Three other groups of drugs will also be more accessible under the new provincial plan coming into effect Aug. 1.
The seven new drugs being added to the provincial formulary are: Alendronate, criteria change for the treatment of osteoporosis; Remicade and Enbrel to treat moderate to severe forms of plaque psoriasis; Pegasys, Baraclude and Hepsera as a second-line treatment for Hepatitis B to be used when other treatments are not effective; and, Emend to reduce nausea and vomiting in patients who are being treated with chemotherapy when other treatments have not been effective.
The three classes of prescription medications being moved from special authorization to open benefit account for approximately 30 per cent of all special authorization requests provincially.
They are: Generic Omeprazole and Rabeprazole to treat various stomach problems such as acid reflux and ulcers; Lamotrigine to treat seizures and bipolar disorder; and Angiotensin II Receptor Blockers for high blood pressure.
More information about the prescription drug program and accessibility of certain drugs can be found at www.gov.nl.ca/health/nlpdp/default.htm
The Telegram is committed to encouraging intelligent discourse among our readers and to creating a forum where diverse views and opinions on a wide range of topics can be aired. The forum you are in now is a result of our continuing efforts to facilitate a dynamic online conversation among our readers.
This is a moderated conversation. Once a reader follows the steps to register and submit his or her comment it goes to a moderator for the website. Once it has been approved, your comment will be displayed on the website. A comment may be edited or deleted for reasons of content or language.
All readers wishing to join a conversation must first sign in and agree to the Terms of Usage, which explain the rules of acceptable content.
- there are currently no comments for this story -
1
